Skip to content
BioHarvest Sciences
  • About
    • Technology
    • Our Team
    • Contact
    • FAQ
  • Therapeutic Solutions
    • Nutraceuticals
    • CDMO Services
  • Our Competitive Advantage
    • Clinical Studies
    • Sustainability
  • News
  • Investors
BioHarvest Sciences
  • About
    • Technology
    • Our Team
    • Contact
    • FAQ
  • Therapeutic Solutions
    • Nutraceuticals
    • CDMO Services
  • Our Competitive Advantage
    • Clinical Studies
    • Sustainability
  • News
  • Investors

November 2021

BHSC NOVEMBER NEWSLETTER

2021 / Sam Chaloub

BHSC NOVEMBER NEWSLETTER Read More »

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS

2021 / Sam Chaloub

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Read More »

BIOHARVEST SCIENCES NEW 20 TONS PER YEAR FACTORY OBTAINS THE GMP (GOOD MANUFACTURING PRACTICES) CERTIFICATION FROM THE ISRAELI MINISTRY OF HEALTH

2021 / Sam Chaloub

BIOHARVEST SCIENCES NEW 20 TONS PER YEAR FACTORY OBTAINS THE GMP (GOOD MANUFACTURING PRACTICES) CERTIFICATION FROM THE ISRAELI MINISTRY OF HEALTH Read More »

NEW RESEARCH ANALYSIS SHOWS VINIA® REDUCES OXIDATION OF LDL-CHOLESTEROL TO SUPPORT CARDIOVASCULAR IMPROVED FUNCTIONING

2021 / Sam Chaloub

NEW RESEARCH ANALYSIS SHOWS VINIA® REDUCES OXIDATION OF LDL-CHOLESTEROL TO SUPPORT CARDIOVASCULAR IMPROVED FUNCTIONING Read More »

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS

2021 / Sam Chaloub

VANCOUVER, BC, October 29, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has granted a total of 113,200 stock options to employees and consultants. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.40 per share for a term of 10 years. 100,000 stock

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Read More »

Recent Posts

  • BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
  • BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
  • BioHarvest Sciences Reports First Quarter 2025 Financial Results
  • BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
  • BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

Recent Comments

No comments to show.

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • April 2020

Categories

  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025
  • Uncategorized

Join Our Newsletter

Be the first to receive our news alerts, event notifications, and product releases.

Revolution
Logo
Facebook X-twitter Linkedin Youtube
  • About
    • Technology
    • Our Team
    • Contact
    • FAQ
  • Therapeutic Solutions
    • Nutraceuticals
    • CDMO Services
  • Our Competitive Advantage
    • Clinical Studies
    • Sustainability
  • News
  • Investors